Report

COVID-19 induced demand pause

COVID-19 is a highly infectious pathogen, not only for humans but also corporates. Indeed there were 55 LSE announcements yesterday alone, detailing how businesses were being impacted by this sudden global pandemic.

Similarly today Mpac said it was beginning to experience slowing activity levels and difficulties accessing client premises to fulfil shipments (re social distancing).

Sure this is frustrating, however we reckon the majority of its orderbook (£52.2m Dec’19) should be completed at a later date. Yes, delays will undoubtedly hit 2020 results – probably more so in Q2 than H2. Yet the longer term fundamentals of Industry 4.0, direct to consumer deliveries and the shift towards more environmentally friendly packaging, continue to play to Mpac’s strengths.

Elsewhere the balance sheet is strong, sporting £18.1m of net cash (89p/share) as at Feb’20 (ie £19m less £0.9m of preference shares), alongside a fully undrawn £10m credit line. Moreover the group has come through these types of short, sharp, economic shock before. And besides, there are other levers to pull if things were to significantly deteriorate. Not least, reducing capex (£2.3m 2019), discretionary spend and non-essential purchases.

Lastly the Board has decided to cancel the previously recommended final dividend of 1.5p - whilst also evaluating government support measures available across various jurisdictions. Likewise, we have temporarily withdrawn our forecasts until there’s greater clarity surrounding COVID-19. But believe at 205p, the stock is attractively priced, trading on trailing 5.2x PE and 6.6x EV/EBIT (pension adjusted) multiples.

How long will all this go on for? Unfortunately nobody knows, albeit the political mood music in Washington seems to be now questioning whether ‘the cure is worse than the disease’. With President Trump stating he ideally wants to ‘re-open’ the US economy by the 12th April Easter holiday. Maybe a little premature, but an aspirational target nonetheless. North America of course is Mpac’s largest market (58% 2019 sales).
Underlyings
Hill & Smith Holdings PLC

Melrose Industries PLC

Mpac Group

Mpac Group is focused on its Packaging Machinery business, Mpac Langen, which designs, precision engineers and manufactures packaging solutions, machinery and high specification automation, secondary packaging equipment and end-of-line robotics and at-line instrumentation and testing solutions as well as providing solutions including the design and integration of packaging systems.

SIG Combibloc Group Ltd

SIG Holding AG. SIG Combibloc Group AG is a Switzerland-based company engaged in the containers and packaging industry. The Company manufactures aseptic carton solutions for beverage and liquid food products, ranging from juices and milk to soups and sauces. The Company's product offering consists of aseptic carton packaging filling machines, aseptic carton packaging sleeves, spouts and caps, as well as after-market services. The Company's machinery is automated with software solutions, such as Efficiency Control System (ECS) and Line Monitoring System (LMS). In addition, the Company provides consulting services, ranging from market analysis and product design to the installation, start-up and maintenance of the filling equipment, food safety consulting and continuous improvement of production facilities and processes. The Company is globally active, with operations in the Americas (AM), Europe (EU), Middle East and Africa (MEA), and Asia-Pacific (AP).

Provider
Equity Development
Equity Development

​Equity Development enables companies to become better understood and supported by investors. Since our launch in 1996 we have consistently focused on helping our clients improve their communication and relationships with both existing and potential shareholders. Our clients have come from a wide variety of sectors and domiciles, are both private and quoted and range in size from micro-cap to $multi-billions. We offer free access to company research notes written by experienced analysts. These notes include detailed forecasts, financial models and a fair value. We host regular Private Investor Forums at which investors have the opportunity to hear company directors present, and to ask questions. These are free to attend. We broadcast live Webinars with company management that include active Q&A. We also make the recordings available online. We arrange face to face meetings between private investors and company management. We are active users of Twitter, commenting daily on company news, share price moves, Directors’ Dealings, Equity Development Research Notes & Events.

Analysts
Paul Hill

Other Reports on these Companies
Other Reports from Equity Development

ResearchPool Subscriptions

Get the most out of your insights

Get in touch